Click to see all articles in our 2021 3D Printing Industry Review of the Year series. March was another busy business month for 3D printing, with the industry’s IPO trend continuing apace and some of …
ROKIT Healthcare to go public on Korean Stock Exchange “by August 2021”
Leading 3D bioprinter manufacturer ROKIT Healthcare is preparing to go public on the Korean Stock Exchange by “July or August 2021,” according to Bioworld sources. Backed by financial service pr…
ROKIT Healthcare develops novel 3D bioprinting method to treat lesions
ROKIT Healthcare, a Korean 3D bioprinter manufacturer previously known as ROKIT, has introduced a novel 3D bioprinting method to treat scarred lesions. Using the company’s 3D bioprinter, the ROKIT INV…